Showing results (41-50 of 145) with videos related to

Sort By:
Pageof 15
Clinics (Sao Paulo, Brazil)|October 21, 2016
Velocity time integral for right upper pulmonary vein in VLBW infants with patent ductus arteriosusGianluca Lista, Silvia Bianchi, Savina Mannarino, et al.
Early Human Development|April 9, 2014
Late-onset neonatal group B streptococcal disease associated with breast milk transmission: molecular typing using RAPD-PCRMicaela Brandolini, Marta Corbella, Patrizia Cambieri, et al.
Early Human Development|April 9, 2014
New diagnostic possibilities in systemic neonatal infections: metabolomicsAngelica Dessì, Giovanni Corsello, Mauro Stronati, et al.
American Journal of Perinatology|April 26, 2018
Novel Approaches to the Study of Neonatal InfectionsAlessandro Borghesi, Mauro Stronati, Riccardo Castagnoli, et al.
Journal of Medical Virology|April 30, 2014
Maternal, fetal, and neonatal parameters for prognosis and counseling of HCMV congenital infectionMaurizio Zavattoni, Giuseppina Lombardi, Vanina Rognoni, et al.
Early Human Development|July 2, 2013
Global perfusion assessment and tissue oxygen saturation in preterm infants: where are we?Rosa Maria Cerbo, Roberta Maragliano, Margherita Pozzi, et al.
Early Human Development|January 22, 2011
Antifungal prophylaxis in neonatesPaolo Manzoni, Evelyne Jacqz-Aigrain, Stefano Rizzollo, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|November 21, 2009
Drug transporters and renal drug disposition in the newbornSimona De Gregori, Manuela De Gregori, Guglielmina Nadia Ranzani, et al.
Journal of Biopharmaceutical Statistics|July 18, 2022
What is the expected benefit of patient-centric clinical development in oncology?Alessandra Serra, Pavel Mozgunov, Thomas Jaki, et al.
Pharmaceutical Statistics|July 7, 2023
Determining the minimum duration of treatment in tuberculosis: An order restricted non-inferiority trial designAlessandra Serra, Pavel Mozgunov, Geraint Davies, et al.
Pageof 15